Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author exact 002000397553 or (type exact bookEditor and editor exact 002000397553)

Add to list
Microvascular effects of the low molecular weight heparins in a colorectal xenograft model: an intravital microscopy study

ISABELLE DEBERGH (UGent) , Piet Pattyn (UGent) and Wim Ceelen (UGent)

(2015) JOURNAL OF SURGICAL RESEARCH. 194(2). p.488-495
Add to list
- Journal Article
- A1
- open access
Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ3 integrin

ISABELLE DEBERGH (UGent) , Nancy Van Damme (UGent) , Dieter De Naeyer (UGent) , Peter Smeets (UGent) , Pieter Demetter, Philippe Robert, Sabin Carme, Piet Pattyn (UGent) and Wim Ceelen (UGent)

(2014) ANNALS OF SURGICAL ONCOLOGY. 21(6). p.2097-2104
Add to list
- PhD Thesis
- open access
Integrated study of the effects of antiangiogenic therapy on microvascular physiology in human cancer models

ISABELLE DEBERGH (UGent)

(2014)
Add to list
Innovation in cancer imaging

ISABELLE DEBERGH (UGent) , Christian Vanhove (UGent) and Wim Ceelen (UGent)

(2012) EUROPEAN SURGICAL RESEARCH. 48(3). p.121-130
Add to list
First order correction for T*2-relaxation in determining contrast agent concentration from spoiled gradient echo pulse sequence signal intensity

Dieter De Naeyer (UGent) , ISABELLE DEBERGH (UGent) , Yves De Deene (UGent) , Wim Ceelen (UGent) , Patrick Segers (UGent) and Pascal Verdonck (UGent)

(2011) JOURNAL OF MAGNETIC RESONANCE IMAGING. 34(3). p.710-715
Add to list
Antitumour efficacy of two paclitaxel formulations for hyperthermic intraperitoneal chemotherapy (HIPEC) in an in vivo rat model

Wim Bouquet-Geerardyn, Steven Deleye, Steven Staelens (UGent) , Lieselotte De Smet (UGent) , Nancy Van Damme (UGent) , ISABELLE DEBERGH (UGent) , Wim Ceelen (UGent) , Filip De Vos (UGent) , Jean Paul Remon (UGent) and Chris Vervaet (UGent)

(2011) PHARMACEUTICAL RESEARCH. 28(7). p.1653-1660
Add to list
The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model

ISABELLE DEBERGH (UGent) , Nancy Van Damme (UGent) , Piet Pattyn (UGent) , Marc Peeters (UGent) and Wim Ceelen (UGent)

(2010) BRITISH JOURNAL OF CANCER. 102(5). p.837-843
Add to list
- Conference Paper
- C3
Low molecular weight heparin inhibits tumor associated angiogenesis in vivo

ISABELLE DEBERGH (UGent) , Nancy Van Damme (UGent) , Piet Pattyn (UGent) , Marc Peeters (UGent) and Wim Ceelen (UGent)

(2009) ACTA GASTRO-ENTEROLOGICA BELGICA. 72.
Add to list
- Conference Paper
- C3
Low molecular weight heparin inhibits tumor associated angiogenesis in vivo

ISABELLE DEBERGH (UGent) , Nancy Van Damme (UGent) , Piet Pattyn (UGent) , Marc Peeters (UGent) and Wim Ceelen (UGent)

(2009) ANNALS OF ONCOLOGY. 20(suppl. 7). p.54-54
Add to list
- Conference Paper
- C3
MOLECULAR IMAGING OF TUMOR ASSOCIATED ANGIOGENESIS USING P1227, A NOVEL MRI CONTRAST AGENT TARGETING AVB3 INTEGRIN

ISABELLE DEBERGH (UGent) , Nancy Van Damme (UGent) , Peter Smeets (UGent) , P Demetter, S Carme, Piet Pattyn (UGent) , M Peeters and Wim Ceelen (UGent)

(2009) ANNALS OF ONCOLOGY. 20. p.30-30
Add to list
- Conference Paper
- C3
Molecular imaging of tumor associated angiogenesis using P1227, a noval MRI contrast agent targeting Alfa V Beta 3 integrin

ISABELLE DEBERGH (UGent) , Nancy Van Damme (UGent) , Peter Smeets (UGent) , Piet Pattyn (UGent) , Marc Peeters (UGent) and Wim Ceelen (UGent)

(2008) ACTA GASTRO-ENTEROLOGICA BELGICA. 71. p.R01-R01
Add to list
- Conference Paper
- C3
Molecular imaging of tumor associated angiogenesis uzing P1127, a novel MRI contrast agent targeting alfa V beta 3 integrin

ISABELLE DEBERGH (UGent) , Nancy Van Damme (UGent) , Peter Smeets (UGent) , Marc Peeters (UGent) , Piet Pattyn (UGent) and Wim Ceelen (UGent)

(2008)
Add to list
- Conference Paper
- C1
Effects of the low molecular weight heparin nadroparin on tumour associated angiogenesis

ISABELLE DEBERGH (UGent) , Nancy Van Damme (UGent) , Marc Peeters (UGent) , Piet Pattyn (UGent) and Wim Ceelen (UGent)

(2008) Annals of Oncology. 19(Suppl 6). p.176-176
Add to list
- Conference Paper
- C3
Effects of the low molecular weight heparin nadroparin on tumor associated angiogenesis

ISABELLE DEBERGH (UGent) , Nancy Van Damme (UGent) , Piet Pattyn (UGent) , Marc Peeters (UGent) and Wim Ceelen (UGent)

(2008) ANNALS OF ONCOLOGY. 19. p.73-73
Add to list
- Conference Paper
- C3
EFFECTS OF THE LOW MOLECULAR WEIGHT HEPARIN NADROPARIN ON TUMOR ASSOCIATED ANGIOGENESIS

ISABELLE DEBERGH (UGent) , Marc Peeters (UGent) and Wim Ceelen (UGent)

(2008) ANNALS OF ONCOLOGY. 19. p.49-49

Academic Bibliography

Microvascular effects of the low molecular weight heparins in a colorectal xenograft model: an intravital microscopy study

Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ3 integrin

Integrated study of the effects of antiangiogenic therapy on microvascular physiology in human cancer models

Innovation in cancer imaging

First order correction for T*2-relaxation in determining contrast agent concentration from spoiled gradient echo pulse sequence signal intensity

Antitumour efficacy of two paclitaxel formulations for hyperthermic intraperitoneal chemotherapy (HIPEC) in an in vivo rat model

The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model

Low molecular weight heparin inhibits tumor associated angiogenesis in vivo

Low molecular weight heparin inhibits tumor associated angiogenesis in vivo

MOLECULAR IMAGING OF TUMOR ASSOCIATED ANGIOGENESIS USING P1227, A NOVEL MRI CONTRAST AGENT TARGETING AVB3 INTEGRIN

Molecular imaging of tumor associated angiogenesis using P1227, a noval MRI contrast agent targeting Alfa V Beta 3 integrin

Molecular imaging of tumor associated angiogenesis uzing P1127, a novel MRI contrast agent targeting alfa V beta 3 integrin

Effects of the low molecular weight heparin nadroparin on tumour associated angiogenesis

Effects of the low molecular weight heparin nadroparin on tumor associated angiogenesis

EFFECTS OF THE LOW MOLECULAR WEIGHT HEPARIN NADROPARIN ON TUMOR ASSOCIATED ANGIOGENESIS

Contents

Support

Contact